Implanet SA designs, produces, and sells medical implants and devices used in orthopedic surgery. The group's products include spinal bracing systems, intersomatic cages, pins, suture threads, screws, anchors, etc. Net sales break down by activity as follows: - sale of implants and devices for spinal surgery (68.6%); - distribution of medical equipment (31.3%). Net sales are distributed geographically as follows: France (35.6%), the United States (30.8%) and other (33.6%).

Employees

Sector

Medical Equipment, Supplies & Distribution

Calendar

09-14 - Earnings release - Q2 2026

More about the company

Market Cap	24.42M 27.85M 22.51M 21.07M 39.52M 2.63B 40.34M 271M 105M 1.3B 105M 102M 4.5B	P/E 2024	-2.85x	P/E 2025	-5.8x
Enterprise Value	27.34M 31.18M 25.2M 23.59M 44.23M 2.94B 45.15M 303M 117M 1.45B 117M 115M 5.04B	EV / Sales 2024	2x	EV / Sales 2025	2.23x
Free-Float	33.85%	Yield 2024 *	-	Yield 2025	-

04-14	Implanet S.A. Reports Unaudited Revenue Results for the First Quarter Ended March 31, 2026	CI
04-13	Weekly Earnings Calendar: JPMorgan and Netflix in the US, LVMH and ASML in Europe,
03-26	Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-05	Shanghai Sanyou Medical's Implanet Secures FDA Clearance for 3D-Printed Spinal System	MT
03-04	Dassault Aviation, Scor... Stocks to Watch Today in Paris -
03-03	IMPLANET Receives FDA Clearance for the Swingo Anterior Cervical Cage	CI
03-03	Euroapi, JCDecaux, GTT... Stocks to Watch Tomorrow in Paris
03-03	Implanet's Swingo Range Approved in the United States
02-25	Alten, Bic, Interparfums, Ipsos, OPMobility, Seb... Key Stocks to Watch Today in Paris
02-24	Alten, Bic, Ipsos... Stocks to Watch Tomorrow
02-24	Implanet Unveils Annual Results and Outlines 2026 Roadmap
01-14	Engie, Safran, Scor, TotalEnergies... Stocks to Watch Today in Paris
01-13	Implanet S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

06-25	IMPLANET to Sponsor Tech Talks at State of Spine Surgery Think Tank	BU
04-20	Minutes of IMPLANET’s Annual General Meeting Held on April 17, 2026	BU
04-14	IMPLANET Reports Q1 2026 Revenue of €3.03 Million, up 18%	BU
03-03	IMPLANET Receives FDA Clearance in the United States for the 3D Cage Range – Swingo™	BU
02-24	Implanet : Inside Information / News release on accounts, results	PU

04-20	Compte rendu de l’Assemblée Générale Mixte d’IMPLANET du 17 avril 2026
04-14	IMPLANET annonce un chiffre d’affaires de 3,03 M€ au 1er trimestre 2026, en progression de +18%
04-09	Implanet : Exposé sommaire de l'activité
04-09	Implanet : Rapport du Commissaire aux comptes - Délégation BSA
04-09	Implanet : Rapport du Commissaire aux comptes - Délégation réduction de capital

Manager	Title	Age	Since
Ludovic Lastennet CEO	Chief Executive Officer	-	2012-11-26
David Dieumegard DFI	Director of Finance/CFO	-	2015-08-31
Yvanna Peigné COO	Chief Operating Officer	-	-

Implanet SA Stock Euronext Paris

Stocks

ALIMP

FR0010458729

Medical Equipment, Supplies & Distribution

Valuation: Implanet SA

Latest news : Implanet SA

Analysts' recommendations: Implanet SA

Press Releases: Implanet SA

News in other languages: Implanet SA

Quotes and Performance

Managers and Directors: Implanet SA

Medical Devices & Implants

Financials

Company Profile

Director	Title	Age	Since
Jean-Gérard Galvez CHM	Chairman	71	2011-04-05
Ludovic Lastennet BRD	Director/Board Member	-	2013-01-21
Paula Ness Speers BRD	Director/Board Member	-	2014-06-09

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IMPLANET SA	-2.86%	-6.85%	-	-	27.85M
STRYKER CORPORATION	+5.25%	+8.09%	-15.46%	+10.80%	128B
SMITH & NEPHEW PLC	-0.04%	+2.33%	+2.38%	-8.55%	12.77B
GLAUKOS CORPORATION	+1.30%	+10.51%	+42.40%	+105.32%	8.48B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-3.88%	-6.41%	-50.35%	-73.01%	3.79B
DOUBLE MEDICAL TECHNOLOGY INC.	-0.38%	-0.97%	+17.82%	+35.82%	2.52B
L&C BIO CO.,LTD	-9.06%	+4.50%	+217.06%	+149.44%	1.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-8.75%	-13.25%	-26.08%	-26.91%	1.53B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.80%	-3.48%	-1.60%	-23.46%	1.53B
Average	-2.36%	-0.05%	+23.27%	+21.18%	19.96B
Weighted average by Cap.	+3.96%	+6.82%	-8.97%	+13.34%

	2024	2025
Net sales	9.41M 10.73M 8.67M 8.12M 15.22M 1.01B 15.54M 104M 40.32M 500M 40.28M 39.4M 1.73B	12.47M 14.23M 11.5M 10.76M 20.19M 1.34B 20.6M 138M 53.48M 663M 53.42M 52.25M 2.3B
Net income	-4.37M -4.98M -4.02M -3.77M -7.07M -470M -7.21M -48.37M -18.72M -232M -18.7M -18.29M -805M	-4.38M -5M -4.04M -3.78M -7.09M -471M -7.24M -48.55M -18.79M -233M -18.77M -18.36M -808M
Net Debt	4.57M 5.21M 4.21M 3.94M 7.39M 492M 7.55M 50.62M 19.59M 243M 19.57M 19.14M 842M	2.92M 3.32M 2.69M 2.52M 4.72M 314M 4.82M 32.3M 12.5M 155M 12.48M 12.21M 537M